MEPRACID

This brand name is authorized in Nigeria.

Active ingredients

The drug MEPRACID contains one active pharmaceutical ingredient (API):

1	Omeprazole UNII KG60484QX9 - OMEPRAZOLE
	Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.
	Read more about Omeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100731	Capsule	Mepracid Capsules Omeprazole_ CAP 20 mg 2 x 10's	Hard Capsule. 34 NF-PP-313658 MEPRACID CAPSULES OMEPRAZOLE OMEPRAZOLE ENTERIC COATED PELLET 8.5% W/W (EQUIVALENT TO 20MG OMEPRAZOLE) 470.58G Drugs Nigerian Products 2x10capsules POM 1 2/9/2023 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria	31/07/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100731